Ophthalmology Workspace

AI-assisted retinal and eye disease analysis at scale.

The NorthNeuron Ophthalmology workspace brings AI-assisted analysis to eye disease screening helping ophthalmologists and optometrists detect vision-threatening conditions earlier, across more patients, with greater clinical confidence.

Eye Disease AI

Conditions Supported

Four leading causes of preventable vision loss one intelligent workspace.

Diabetes Complication

Diabetic Retinopathy

Grading and screening for the leading preventable cause of blindness worldwide.

Diabetic retinopathy affects one in three people with diabetes. AI-assisted grading of fundus photographs enables systematic screening at scale supporting earlier intervention and helping prevent irreversible vision loss across large diabetic populations.

Progressive

Glaucoma Screening

AI-assisted detection of glaucoma markers for early clinical intervention.

Glaucoma is the silent thief of sight often asymptomatic until significant vision loss has occurred. AI analysis supports earlier detection of optic disc changes and other retinal markers, enabling timely referral for specialist management.

Age-Related

Age-Related Macular Degeneration (AMD)

Recognition of AMD patterns from early drusen to advanced degeneration.

AMD is the leading cause of vision loss in adults over 50. AI-assisted analysis identifies early drusen deposits, geographic atrophy, and neovascular changes supporting stratified care pathways and monitoring of at-risk patients.

Lens Assessment

Cataract Assessment

Lens opacity classification to support cataract screening at population scale.

Cataracts are the leading cause of reversible blindness globally. AI-assisted opacity grading supports systematic cataract screening programs helping identify surgical candidates and prioritise intervention in underserved populations.

For Ophthalmologists & Optometrists

Screening at the speed and scale that vision care demands.

  • Systematic screening support for large diabetic and aged care patient populations.
  • Structured grading outputs with confidence scoring not just a binary yes/no finding.
  • Earlier detection of conditions where timely intervention prevents irreversible harm.
  • Clinician-readable summaries ready to inform referral and treatment decisions.
  • Full audit trail every AI assessment is logged, reviewable, and traceable.

The Opportunity in Ophthalmology

AI makes specialist-quality screening accessible where it's needed most.

  • Extend ophthalmology reach to primary care and community health settings.
  • Process large screening queues without compromising per-patient analysis depth.
  • Support national and regional diabetic eye disease screening programs.
  • Identify at-risk patients earlier when intervention is still most effective.

Protecting Vision with AI

Bring AI-assisted eye disease screening to your ophthalmology program.

Earlier detection. More consistent screening. Better outcomes for patients at risk of preventable vision loss. Let's talk about how NorthNeuron fits your ophthalmology workflow.